TRAF3IP1 (Center), 396-423 Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-TRAF3IP1 (Center), 396-423 antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | TRAF3IP1 (Center), 396-423 |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | n/a |
| Format | peptide affinity purified |
| Size | 0.08 mL, 0.4 mL |
| Concentration | vial concentration: 0.5 |
| Applications | Western Blot (WB), ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This TRAF3IP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 396-423 amino acids from the Central region of human TRAF3IP1. TRAF3IP1 play an inhibitory role on IL13 signaling by binding to IL13RA1. Involved in suppression of IL13-induced STAT6 phosphorylation, transcriptional activity and DNA-binding. Recruits TRAF3 and DISC1 to the microtubules. |
| Immunogen | n/a |
| Other Names | [TRAF3-interacting protein 1; Interleukin-13 receptor alpha 1-binding protein 1; Intraflagellar transport protein 54 homolog; Microtubule-interacting protein associated with TRAF3; MIP-T3; TRAF3IP1; IFT54; MIPT3] |
| Gene, Accession # | [TRAF3IP1], Gene ID: 26146, NCBI: NP_001132962.1, UniProt: Q8TDR0 |
| Catalog # | MBS9208027 |
| Price | $165, $370 |
| Order / More Info | TRAF3IP1 (Center), 396-423 Antibody from MYBIOSOURCE INC. |
| Product Specific References | Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) : Guo, C.W., et al. Proteomics 10(12):2337-2347(2010) Ross, C.J., et al. Nat. Genet. 41(12):1345-1349(2009) Tomppo, L., et al. Biol. Psychiatry 65(12):1055-1062(2009) Camargo, L.M., et al. Mol. Psychiatry 12(1):74-86(2007) |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies